• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体肝脏样本中的维生素K代谢及维生素K1状态:探寻个体对华法林敏感性的差异

Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity.

作者信息

Thijssen H H, Drittij-Reijnders M J

机构信息

Department of Pharmacology, University of Limburg, Maastricht, The Netherlands.

出版信息

Br J Haematol. 1993 Aug;84(4):681-5. doi: 10.1111/j.1365-2141.1993.tb03146.x.

DOI:10.1111/j.1365-2141.1993.tb03146.x
PMID:8217828
Abstract

Vitamin K-dependent parameters in human liver samples were investigated to find a clue to the inter-individual differences in sensitivity for oral anticoagulants. Vitamin K epoxide reductase and vitamin K-dependent carboxylase activity differed 2-3-fold between the samples. Microsomal warfarin binding correlated significantly with the reductase activity. Microsomal vitamin K epoxide reductase of the different samples showed equal sensitivity for warfarin inhibition, I50 about 0.1 microM. Vitamin K epoxide reductase activity stimulated by NADH/lipoamide and microsomal lipoamide dehydrogenase activity showed higher inter-subject variability than the reductase activity by itself. Liver vitamin K1 levels varied 4-5-fold. Total and liver microsomal vitamin K1 levels were correlated. One of the liver samples was obtained from a donor anticoagulated with phenprocoumon and additionally treated with vitamin K1. High levels of the vitamin and its epoxide were present. Phenprocoumon was essentially irreversibly bound to the microsomes. In general the results confirm inter-individual differences in the hepatic vitamin K-dependent systems; the differences as such were found to be small. However, as the various parameters can work synergistically in the same direction, they may well account for the wide dose range observed in oral anticoagulant therapy.

摘要

研究了人肝脏样本中维生素K依赖参数,以寻找口服抗凝剂个体敏感性差异的线索。样本间维生素K环氧化物还原酶和维生素K依赖羧化酶活性相差2至3倍。微粒体华法林结合与还原酶活性显著相关。不同样本的微粒体维生素K环氧化物还原酶对华法林抑制表现出相同的敏感性,半数抑制浓度(I50)约为0.1微摩尔。由烟酰胺腺嘌呤二核苷酸(NADH)/硫辛酰胺刺激的维生素K环氧化物还原酶活性和微粒体硫辛酰胺脱氢酶活性比还原酶活性本身表现出更高的个体间变异性。肝脏维生素K1水平相差4至5倍。总维生素K1水平与肝脏微粒体维生素K1水平相关。其中一个肝脏样本取自用苯丙香豆素抗凝并额外用维生素K1治疗的供体。样本中存在高水平的维生素及其环氧化物。苯丙香豆素基本上不可逆地与微粒体结合。总体而言,结果证实了肝脏维生素K依赖系统存在个体间差异;发现这种差异很小。然而,由于各种参数可在同一方向协同作用,它们很可能解释了口服抗凝治疗中观察到的广泛剂量范围。

相似文献

1
Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity.人体肝脏样本中的维生素K代谢及维生素K1状态:探寻个体对华法林敏感性的差异
Br J Haematol. 1993 Aug;84(4):681-5. doi: 10.1111/j.1365-2141.1993.tb03146.x.
2
The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat.醋硝香豆素、苯丙香豆素和华法林对大鼠各组织中维生素K环氧化物还原酶和维生素K依赖性羧化酶的体内作用。
Biochim Biophys Acta. 1986 Oct 29;884(1):150-7. doi: 10.1016/0304-4165(86)90238-2.
3
Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.肝脏中维生素K依赖的羧化作用和维生素K代谢。华法林的作用
J Clin Invest. 1985 Nov;76(5):1879-84. doi: 10.1172/JCI112182.
4
Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.微粒体硫辛酰胺还原酶为维生素K环氧化物还原酶提供还原当量。
Biochem J. 1994 Jan 15;297 ( Pt 2)(Pt 2):277-80. doi: 10.1042/bj2970277.
5
Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.维生素K1 2,3-环氧化物还原酶体外活性的物种比较:动力学与华法林抑制作用
Toxicology. 2003 Aug 1;189(3):191-8. doi: 10.1016/s0300-483x(03)00133-1.
6
Evidence that warfarin anticoagulant action involves two distinct reductase activities.华法林抗凝作用涉及两种不同还原酶活性的证据。
J Biol Chem. 1982 Oct 10;257(19):11210-2.
7
Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
Biochem Pharmacol. 1989 Apr 1;38(7):1115-20. doi: 10.1016/0006-2952(89)90257-8.
8
Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.香豆素作用机制:正常及对华法林耐药大鼠肝脏中维生素K代谢酶的敏感性
Biochemistry. 1982 May 11;21(10):2406-11. doi: 10.1021/bi00539a020.
9
Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.华法林对大鼠血浆和肝脏维生素K水平以及维生素K环氧化物还原酶活性的影响及其与血浆凝血因子水平的关系。
Thromb Res. 1990 Jan 15;57(2):205-14. doi: 10.1016/0049-3848(90)90320-c.
10
Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle.微粒体环氧化物水解酶与维生素K循环中对华法林敏感的维生素K1氧化还原酶的共纯化。
Biochem Pharmacol. 1998 Jan 15;55(2):169-75. doi: 10.1016/s0006-2952(97)00431-0.

引用本文的文献

1
Ethnic differences in the population pharmacokinetics and pharmacodynamics of warfarin.华法林群体药代动力学和药效学的种族差异。
J Pharmacokinet Pharmacodyn. 2010 Feb;37(1):3-24. doi: 10.1007/s10928-009-9138-4. Epub 2009 Nov 26.
2
Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.华法林撤药。药代动力学-药效学考量。
Clin Pharmacokinet. 1996 Apr;30(4):300-13. doi: 10.2165/00003088-199630040-00003.
3
Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.微粒体硫辛酰胺还原酶为维生素K环氧化物还原酶提供还原当量。
Biochem J. 1994 Jan 15;297 ( Pt 2)(Pt 2):277-80. doi: 10.1042/bj2970277.